Mycobacterium heckeshornense lumbar spondylodiskitis in a patient with rheumatoid arthritis receiving etanercept treatment.
Elyousfi
Abdulhamid A
AA
Leiter
Jeff R S
JR
Goytan
Micheal J
MJ
Robinson
David B
DB
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D015299:Discitis / Q000175:diagnosis* / Q000382:microbiology*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000382:microbiology* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009161:Mycobacterium / Q000472:pathogenicity*; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000382:microbiology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept